Michael Berelowitz Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael Berelowitz.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael Berelowitz. Michael Berelowitz is Director in ORAMED PHARMACEUTICALS INC. ($IGVL) and Director in Recro Pharma, Inc. ($REPH).

Latest Insider Trading Transactions of Michael Berelowitz

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ORMP, REPH

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 22 2021	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	1.71	38,012	65,001	38,012
Apr 22 2021	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Grant	A	0.00	26,923	0	76,546	49.6 K to 76.5 K (+54.26 %)
May 11 2020	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	8.37	12,405	103,830	12,405
May 11 2020	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Grant	A	0.00	8,363	0	49,623	41.3 K to 49.6 K (+20.27 %)
Dec 09 2019	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Grant	A	0.00	13,848	0	41,260	27.4 K to 41.3 K (+50.52 %)
May 10 2019	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	8.80	10,888	95,814	10,888
May 10 2019	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Grant	A	0.00	7,955	0	27,412	19.5 K to 27.4 K (+40.89 %)
May 08 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Grant	A	0.00	6,183	0	6,183	0 to 6.2 K
Mar 13 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	M	2.47	7,500	18,525	14,500
Mar 13 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Sell	S	10.45	7,500	78,347	0	7.5 K to 0 (-100.00 %)
Mar 13 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Buy	M	2.47	7,500	18,525	7,500	0 to 7.5 K
May 16 2017	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	0.00	13,274	0	13,274
Dec 18 2015	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	8.41	10,000	84,100	10,000
Dec 10 2015	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Sell	S	9.44	700	6,608	22,896	23.6 K to 22.9 K (-2.97 %)
Dec 09 2015	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Sell	S	8.70	761	6,621	23,596	24.4 K to 23.6 K (-3.12 %)
Dec 09 2015	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Sell	S	8.70	539	4,689	24,357	24.9 K to 24.4 K (-2.17 %)
Feb 25 2015	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Grant	A	0.00	22,178	0	24,896	2.7 K to 24.9 K (+815.97 %)
Nov 17 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Grant	A	0.00	2,718	0	2,718	0 to 2.7 K
Apr 11 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Option Exercise	A	12.45	13,094	163,020	13,094
Apr 02 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Option Exercise	M	5.76	6,100	35,136	18,900
Apr 02 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Option Exercise	M	4.08	3,334	13,603	0
Apr 02 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Sell	S	10.50	9,434	99,057	0	9.4 K to 0 (-100.00 %)
Apr 02 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Buy	M	5.76	6,100	35,136	9,434	3.3 K to 9.4 K (+182.96 %)
Apr 02 2014	IGVL	ORAMED PHARMACEUTI ...	Berelowitz Michael	Director	Buy	M	4.08	3,334	13,603	3,334	0 to 3.3 K

Page: 1